Macquarie Group’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-110,260
Closed -$6.06M 1020
2025
Q3
$6.06M Buy
110,260
+26,388
+31% +$1.09M 0.01% 918
2025
Q2
$2.77M Buy
83,872
+9,466
+13% +$329K ﹤0.01% 1136
2025
Q1
$2.99M Sell
74,406
-1,027
-1% -$47.2K ﹤0.01% 1108
2024
Q4
$3.55M Buy
75,433
+1,533
+2% +$79.6K ﹤0.01% 1026
2024
Q3
$3.9M Buy
73,900
+301
+0.4% +$16.8K ﹤0.01% 1034
2024
Q2
$3.99M Sell
73,599
-27,445
-27% -$1.66M ﹤0.01% 1030
2024
Q1
$7.08M Buy
101,044
+59,060
+141% +$4.57M 0.01% 886
2023
Q4
$3.5M Sell
41,984
-5,775
-12% -$209K ﹤0.01% 1061
2023
Q3
$1.41M Buy
47,759
+9,059
+23% +$302K ﹤0.01% 1261
2023
Q2
$1.26M Buy
38,700
+2,276
+6% +$84.2K ﹤0.01% 1312
2023
Q1
$1.28M Sell
36,424
-37,236
-51% -$1.52M ﹤0.01% 1302
2022
Q4
$3.38M Sell
73,660
-40,645
-36% -$1.75M ﹤0.01% 1057
2022
Q3
$5.58M Buy
114,305
+34,847
+44% +$1.68M 0.01% 964
2022
Q2
$3.12M Buy
79,458
+28,156
+55% +$1.13M ﹤0.01% 1151
2022
Q1
$1.89K Buy
51,302
+5,655
+12% +$201K ﹤0.01% 1384
2021
Q4
$2.08M Sell
45,647
-15,316
-25% -$591K ﹤0.01% 1364
2021
Q3
$2.18M Sell
60,963
-13,636
-18% -$401K ﹤0.01% 1362
2021
Q2
$1.48M Sell
74,599
-160
-0.2% -$3.76K ﹤0.01% 1506
2021
Q1
$1.74M Buy
74,759
+4,469
+6% +$95.4K ﹤0.01% 1246
2020
Q4
$1.46M Buy
70,290
+68,333
+3,492% +$1.25M ﹤0.01% 1200
2020
Q3
$42K Hold
1,957
﹤0.01% 1992
2020
Q2
$46K Buy
+1,957
New +$36.7K ﹤0.01% 1955
2018
Q1
Sell
-900
Closed -$7K 2211
2017
Q4
$7K Buy
+900
New +$10.2K ﹤0.01% 2329

Other funds holding CYTK